Agios Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Agios Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 88% to $26,823,000. Profit margin reached -1313%. Total operating expenses were $408,806,000.
Profit Margin
| 2014 | 65.35M | -53.50M | -81.86% |
|---|---|---|---|
| 2015 | 59.11M | -117.73M | -199.14% |
| 2016 | 69.89M | -198.47M | -283.97% |
| 2017 | 43.01M | -314.67M | -731.6% |
| 2018 | 94.38M | -346.02M | -366.61% |
| 2019 | 117.91M | -396.61M | -336.36% |
| 2020 | 203.19M | -335.21M | -164.97% |
| 2021 | 0 | 1.60B | |
| 2022 | 14.24M | -74.55M | -523.56% |
| 2023 | 26.82M | -352.08M | -1312.63% |
AGIO Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 26.82M | 14.24M | 0 | 203.19M | 117.91M | 94.38M | 43.01M | 69.89M | 59.11M | 65.35M |
Cost of revenue | 9.50M | 1.70M | 18.77M | 2.80M | 1.31M | 1.39M | 292.68M | 0 | 141.82M | 100.37M |
Gross profit | 17.31M | 12.53M | -18.77M | 200.39M | 116.59M | 92.99M | -249.67M | 69.89M | -82.70M | -35.01M |
Operating exp. | ||||||||||
Research and development | 288.90M | 279.91M | 256.97M | 367.47M | 410.89M | 341.32M | 292.68M | 220.16M | 141.82M | 100.37M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 408.80M | 401.58M | 378.41M | 516.54M | 542.92M | 455.46M | 363.80M | 270.87M | 177.81M | 119.49M |
Operating income | -391.48M | -389.04M | -378.41M | -316.14M | -426.33M | -362.47M | -320.79M | -200.98M | -118.7M | -54.13M |
Other income (expenses), net | 39.39M | 157.24M | 21.90M | 6.61M | 14.86M | 16.45M | 6.12M | 2.51M | 968K | 203K |
Income before tax | -352.08M | -231.80M | -356.51M | -327.37M | -411.47M | -346.02M | -314.67M | -198.47M | -117.73M | -53.93M |
Income tax expense | 0 | -157.24M | -1.97B | 7.84M | -14.86M | 32.90M | -6.43M | -5.70M | -426K | -426K |
Net income | -352.08M | -74.55M | 1.60B | -335.21M | -396.61M | -346.02M | -314.67M | -198.47M | -117.73M | -53.50M |
Earnings per share | ||||||||||
Basic EPS | -6.33 | -1.36 | 26.55 | -4.86 | -6.61 | -6.03 | -6.75 | -5.07 | -3.15 | -1.59 |
Diluted EPS | -6.33 | -1.36 | 26.55 | -4.86 | -6.61 | -6.03 | -6.75 | -5.07 | -3.15 | -1.59 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |